Pared-down Novogen takes chance on sleep apnoea market with Kai reverse takeover
This article was originally published in Scrip
Executive Summary
Australian biotech company Novogen is further distancing itself from its previous focus on oncology drugs and is moving into medical devices after agreeing to merge with sleep apnoea specialist Kai Medical.